药物耐药性:神脂代谢的作用
Assem Zhakupova1, Adelina Zeinolla1, Kamilya Kokabi1
1Department of Biomedical Sciences, Nazarbayev University School of Medicine, Astana 010000, Kazakhstan.
International journal of molecular sciences
|May 7, 2025
概括
改变的脂代谢,特别是葡萄糖胺合成酶,通过促进细胞存活和药物排放,驱动癌症药物耐药性. 准这些酶可能会恢复化疗的有效性.
科学领域:
- 生物化学 生化学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 癌症药物耐药性显著挑战治疗疗效.
- 脊柱脂代谢失调是一种新兴的机制,有助于癌症抗药性.
- 癌细胞中的改变的脂质通过使药物流出并绕过亡来促进生存.
研究的目的:
- 审查脂酶代谢失调在癌症抗药性中的作用.
- 突出显示葡萄糖胺合成酶 (GCS),氨酸激酶和酸胺酶作为潜在的治疗点.
主要方法:
- 关于脂代谢和癌症抗药性研究的文献综述.
- 分析将脂酶与药物流量和细胞存活联系起来的机制.
- 鉴定涉及脂介导耐药性的关键酶.
主要成果:
- 升级调节的葡萄糖胺合成酶 (GCS) 增加了ABCB1基因表达,导致药物排放量增加.
- 不调节的脂代谢通过防止亡,支持癌细胞的存活.
- 特定的酶,如GCS,斯芬戈氨酸激酶和酸胺酶,都与耐药性有关.
结论:
- 向参与脂代谢的酶提供了一个有希望的策略,以克服癌症药物耐药性.
- 调节脂通路可以提高现有的化疗剂的有效性.
- 对这些目标的进一步研究可能会导致改善癌症治疗结果.
相关概念视频
Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
Carrier-Mediated Transport
215
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
215
Drug Biotransformation: Overview
2.2K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
2.2K
Drug Metabolism: Phase II Reactions
3.4K
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
3.4K
Cellular Membranes and Drug Transport
237
Drugs must traverse multiple biological barriers, such as multi-layered skin, single-layered intestinal epithelium, and the plasma membrane, to reach their target sites within the body. The plasma membrane, a highly structured composite of phospholipids, carbohydrates, and proteins, is the cell's protective boundary, facilitating selective substance exchange.
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.
237
Factors Affecting Drug Biotransformation: Biological
78
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
78


